Sea Moss for Idiopathic Pulmonary Fibrosis: Anti-Inflammatory, TGF-beta/Wnt/Epithelial Fibrosis & Lung Support

Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible fibrosing interstitial lung disease predominantly affecting adults over 60 (~5/10,000), driven by repeated alveolar epithelial microinjury, AEC2 senescence and ER stress, TGF-beta1/SMAD2/3/alpha-SMA myofibroblast activation, Wnt/beta-catenin pro-fibrotic epithelial-mesenchymal transition (EMT), NLRP3 inflammasome/IL-1beta macrophage activation, VEGF-driven aberrant angiogenesis, and telomere attrition. Sea moss fucoidan modulates TGF-beta downstream NF-kB and inflammatory macrophage signaling; selenium supports alveolar epithelial GPx1/4 selenoprotein P antioxidant defense; omega-3 modulates prostaglandin E2 and LTB4 alveolar eicosanoids; zinc supports metalloproteinase MMP balance and Treg immune regulation. Nintedanib (FGFR/VEGFR/PDGFR inhibitor) and pirfenidone (anti-fibrotic) are FDA-approved antifibrotic agents; lung transplant is definitive.

Read the full guide